CMP Pharma specializes in liquid formulations of branded medications to serve patients who may be unable to swallow or have difficulty swallowing traditional formulations.

The FDA has issued guidance on compounding and advises against use when they are essentially copies of FDA-approved alternatives, such as the branded oral liquids offered by CMP Pharma. Pharmacies creating compounded versions of FDA-approved medications may violate the Federal Food, Drug, and Cosmetic Act (FDCA).*

Consider CMP Pharma’s FDA-approved liquid alternatives for patients who need it. See below for more information on our branded oral liquids.

*FDA Guidance, “Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the FD&C Act” (January 2018); 21 CFR § 503A.